Formulation Development is the core activity at Zenvision Pharma and it includes Pre-formulation studies, formulation development, analytical method development & validation, stability studies, Dossier preparation & Technology Transfer. Formulation Development is based on QbD/DoE principles as per the USFDA/EMEA expectations.
Dosage forms & Processes
Zenvision has in-house state of the art formulation, analytical development & well supported by regulatory services, intellectual property management, quality assurance, clinical (BA/BE studies) & project management. Zenvision Pharma offers full support from concept to the commercialisation.
Our advantage is based on offering IP and Regulatory compliant process proposals and approvals by the client for individual’s regions of interest. Our process involves Quality-By-Design (QbD) concepts at all stages of formulation development. The Design of Experiments (DOE) along with relevant time scale and risk assessment helps us to develop the strategy for further experimentation.
Product development is done in compliance with the latest regulatory guidance’s such as ICH Q8, ICH Q9, ICH Q10, QBD
Quality Target Profile (QTP), Critical Quality Attributes (CQA) & Risk assessment are integral part of development
Design of Experiments (DOE) is applied
Patent non-infringing formulation strategy
Proof of concept studies and create a position by proactively patenting technologies thus developed
Early protection to formulation opportunities
Efficient Project management
Creates Value by Innovation
product portfolio management
Zenvision has unique strength in suggesting portfolio/pipeline projects for clients based on their requirement, capabilities and territory. It is a great factor which separates us from the rest.
Zenvision suggests and develop potential products after doing client product analysis, market analysis, disease pattern analysis, demographic analysis and product/dose form feasibility study. It could help the client in introducing highly potential product to the market.